<html>
<head>PUBMED IDs for ANKHD1</head>
<body bgcolor='#C5F0F2'><h1>ANKHD1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16098192/'>Molecular and functional characterization of a novel splice variant of ANKHD1 that lacks the KH domain and its role in cell survival and apoptosis.</a> August 16  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16956752/'>ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cells.</a> September 8  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/23142581/'>ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells.</a> February 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24726915/'>ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells.</a> July 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25483783/'>ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth.</a> April 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25523139/'>ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells.</a> September 16  2014<br></body></html>
